Diane Weiser | SVP, Corporate Communications & IR |
Robert Blum | CEO, President |
Fady Malik | EVP, Research & Development |
Stuart Kupfer | SVP & Chief Medical Officer |
Robert Wong | VP & CAO |
Ching Jaw | SVP & CFO |
Dane Leone | Raymond James |
Jason Butler | JMP Securities |
Joe Pantginis | H.C. Wainwright |
Salim Syed | Mizuho |
Charles Duncan | Cantor Fitzgerald |
Jeff Hung | Morgan Stanley |
Ted Tentoff | Piper Sandler |
Greg Suvannavejh | Goldman Sachs |
Carter Gould | Barclays |
Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics' Fourth Quarter 2020 Conference Call. At this time, I would like to inform you that this call is being recorded. [Operator Instructions] I will now turn the call over to Diane Weiser, Cytokinetics Senior Vice President of Corporate Creations and Investor Relations. Please go ahead.
Good afternoon, and thanks for joining us on the call today.